Preliminary [tmco]    
Report [inpr]    
Controlled Trial [resa]    
MTH-68-B [bacs]    
Vaccine Treatment [topp]    
ACUTE [tmco]    
HEPATITIS [dsyn]    
Phase II Study [resa]    
Eighty [qnco]    
Patients [podg]    
VIRAL HEPATITIS [dsyn]    
Attribute [idcn]    
HEPATITIS B VIRUS [virs]    
HEPATITIS C VIRUS [virs]    
included [ftcn]    
Study [mnob]    
employing [fndg]    
MTH-68-B [bacs]    
Attenuated [qlco]    
Variant [qlco]    
Bursal Disease [dsyn]    
twenty [aggp]    
Patients [podg]    
Hepatitis B virus group [virs]    
HEPATITIS C VIRUS [virs]    
Patients [podg]    
Treated [ftcn]    
MTH-68-B [bacs]    
Remaining [qlco]    
Patients [podg]    
RECEIVED [qlco]    
Conventional Therapy [topp]    
Patients [podg]    
progressed [ftcn]    
Active chronic hepatitis [dsyn]    
Conventional Therapy [topp]    
HEPATITIS B VIRUS [virs]    
HEPATITIS C VIRUS [virs]    
Cases [ftcn]    
Treated [ftcn]    
Groups [idcn]    
Relapses [phpr]    
ED [idcn]    
Frequently [tmco]    
Created [acty]    
Groups [idcn]    
HEPATITIS B VIRUS [virs]    
HEPATITIS C VIRUS [virs]    
Control Groups [grup]    
remissions [fndg]    
One month [tmco]    
treatment [ftcn]    
Observed [ftcn]    
Often [tmco]    
Treated [ftcn]    
Groups [idcn]    
Control Groups [grup]    
HEPATITIS B VIRUS [virs]    
HEPATITIS C VIRUS [virs]    
Patients [podg]    
Duration [tmco]    
HEPATITIS [dsyn]    
Shortened [qlco]    
MTH-68-B [bacs]    
treatment [ftcn]    
HEPATITIS B VIRUS [virs]    
WEEKS [tmco]    
Hepatitis C virus group [virs]    
WEEKS [tmco]    
Presented [idcn]    
Suggest [idcn]    
Attenuated [qlco]    
Pathogenic [orgm]    
VIRUSES [virs]    
Benefit [qnco]    
Patients [podg]    
Viral Hepatitis B [dsyn]    
Infections [patf]    
